Lord, Abbett & Co’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-527,004
| Closed | -$21.3M | – | 504 |
|
2025
Q1 | $21.3M | Buy |
+527,004
| New | +$21.3M | 0.08% | 280 |
|
2023
Q4 | – | Sell |
-779,126
| Closed | -$39.4M | – | 514 |
|
2023
Q3 | $39.4M | Buy |
779,126
+472,898
| +154% | +$23.9M | 0.15% | 199 |
|
2023
Q2 | $14.3M | Buy |
+306,228
| New | +$14.3M | 0.05% | 386 |
|